Skip to main content
. 2020 Apr 28;11:524. doi: 10.3389/fphar.2020.00524

Table 3.

Summary of the main pathways that nanoparticles can take to cross the intestinal epithelium (Yu et al., 2016; Reinholz et al., 2018).

Paracellular
  • Transport through the intercellular space between intestinal epithelial cells (enterocytes)

  • Intercellular spaces have an aqueous environment and rely on passive transport

Limitations
  • Passage of nanoparticles is restricted by the narrow tight junction space (0.3 to 20 nm)

  • Potential for toxicity with the passage of other gastrointestinal content in the chyme

Transcellular
  • Transport through epithelial cells (enterocytes) by transcytosis, which includes endocytosis, intracellular trafficking, and exocytosis

  • Enterocytes represent 90–95% of the cells lining the GI tract

  • Nanoparticles can potentially undergo indirect transport to the systemic circulation via the hepatic portal system or direct transport to the systemic circulation via the intestinal lymphatic system

Limitations
  • Internalized nanoparticles are usually transported to lysosomes that contain a variety of enzymes for degradation

  • Enterocytes have enzymes in the microvilli of the brush border membrane and within the glycocalyx

  • Mucus layer and glycocalyx of enterocytes are thicker compared to M cells

M-cell-mediated
  • Transport through M cells (microfold cells) by transcytosis, which includes endocytosis, intracellular trafficking, and exocytosis

  • M cells are mainly localized in Peyer's patches in the small intestine and have reduced intracellular enzymatic activity

  • Mucus layer and glycocalyx of M cells are considerably thinner compared to enterocytes, allowing easier access

  • Nanoparticles can potentially be captured by macrophages and dendritic cells in the Peyer's patches (beneficial for the development of oral vaccinations) or undergo passive lymphatic targeting followed by systemic drug delivery

Limitations
  • Absorption of nanoparticles is restricted due to the low proportion of M cells (~1%) in the intestinal epithelium

  • Cellular uptake can be low due to a lack of specificity of nanoparticles towards M cells